|
GTPBP4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.493000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.379600E-01 |
| Normal-vs-Stage2 |
8.737800E-01 |
| Normal-vs-Stage3 |
6.350400E-02 |
| Normal-vs-Stage4 |
1.128340E-02 |
| Stage1-vs-Stage2 |
7.646000E-01 |
| Stage1-vs-Stage3 |
4.893900E-02 |
| Stage1-vs-Stage4 |
9.403600E-04 |
| Stage2-vs-Stage3 |
1.713160E-01 |
| Stage2-vs-Stage4 |
2.419900E-02 |
| Stage3-vs-Stage4 |
4.565000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.327600E-01 |
| Normal-vs-AfricanAmerican |
5.120200E-01 |
| Normal-vs-Asian |
2.170600E-01 |
| Caucasian-vs-AfricanAmerican |
8.127400E-01 |
| Caucasian-vs-Asian |
2.414800E-01 |
| AfricanAmerican-vs-Asian |
2.583400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.712200E-01 |
| Normal-vs-Female |
1.557670E-03 |
| Male-vs-Female |
3.162300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.605800E-01 |
| Normal-vs-Extreme_Weight |
7.792800E-01 |
| Normal-vs-Obese |
1.883830E-01 |
| Normal-vs-Extreme_Obese |
1.882400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.930800E-01 |
| Normal_Weight-vs-Obese |
4.548000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.332200E-01 |
| Extreme_Weight-vs-Obese |
1.187640E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.069000E-01 |
| Obese-vs-Extreme_Obese |
1.186010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.959600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.503850E-01 |
| Normal-vs-Age(61-80Yrs) |
8.337600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.075600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.399880E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.017700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.406300E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.499500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.082200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.683600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.574400E-01 |
| Normal-VS-Type2 PRCC |
8.908200E-01 |
| Normal-VS-KIRP CIMP |
1.429600E-04 |
| Normal-VS-Unclassified PRCC |
9.118400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.335200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.72184488889116E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
7.291000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.02809999963571E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
8.319200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.63490000426592E-08 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.789800E-01 |
| Normal-vs-N1 |
5.043200E-03 |
| Normal-vs-N2 |
3.152400E-01 |
| N0-vs-N1 |
1.540410E-03 |
| N0-vs-N2 |
2.691200E-01 |
| N1-vs-N2 |
7.121000E-01 |
|
|
